Open Government Portal

Found 10 records similar to Exceptional importation and sale of drugs in relation to COVID-19: Tier 3 drug shortages

Federal

For the purpose of expanding the list of "designated drugs", the Industry must propose an addition to the list of designated drugs.

Last Updated: May 1, 2020
Date Published: Apr. 6, 2020
Organization: Health Canada
Formats: HTML
Keywords:  Exceptional importation and sale of drugs, tier 3 drug shortages, drug supply, designated drugs
Federal

There is an unprecedented demand and urgent need for access to drugs during the COVID-19 pandemic. On March 30, 2020, the Minister of Health signed the Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19. The interim order (IO) allows certain drugs that may not fully meet regulatory requirements to be imported and sold in Canada.

Last Updated: May 1, 2020
Date Published: Apr. 6, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 pandemic, Interim Order, Special dietary purpose, exceptional importation and sale of drugs.
Federal

the Minister of Health signed the Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19. IO No. 2 extends and modifies certain measures for drugs that were in the first interim order.

Last Updated: Jul. 27, 2021
Date Published: Mar. 1, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, exceptional importation, sale of drugs, medical devices, foods for a Special Dietary, Interim Order, extends and modifies certain measures, large-scale public health emergencies
Federal

The COVID-19 pandemic has created an urgent need for drugs, biocides, medical devices and foods for a special dietary purpose, and affected their supply in Canada. To help prevent or alleviate shortages of these products, the Minister of Health has signed an interim order (IO).

Last Updated: Apr. 30, 2021
Date Published: Mar. 1, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Interim Order, exceptional importation and sale, prevent shortages
Federal

Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment; the Minister of Health, pursuant to subsection 30.1‍(1)Footnote 1 of the Food and Drugs ActFootnote 2, makes the annexed Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

Last Updated: Nov. 4, 2020
Date Published: Sep. 16, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, Interim Order, notice, explanatory note, importation, sale and advertising of drugs, a significant risk to health, safety or the environment
Federal

Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment; the Minister of Health, pursuant to subsection 30.1‍(1)Footnote 1 of the Food and Drugs ActFootnote 2, makes the annexed Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

Last Updated: Nov. 18, 2020
Date Published: Sep. 16, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, Interim Order, notice, explanatory note, importation, sale and advertising of drugs, a significant risk to health, safety or the environment
Federal

A promising COVID-19 drug may be imported into Canada before it receives a Canadian market authorization. This early importation and placement in Canadian facilities is referred to as “pre-positioning.” It facilitates the immediate distribution of the drug upon authorization, making it available to Canadians as early as possible.

Last Updated: Jul. 29, 2021
Date Published: Jun. 14, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, COVID-19 drug, amendement, Food and Drug Regulations, drugs, manufacturers, submission, notice of compliance
Federal

There is an unprecedented demand and urgent need for access to medical devices during the COVID-19 pandemic. On March 30, 2020, the Minister of Health signed the Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19. The interim order (IO) allows certain medical devices that may not fully meet regulatory requirements to be imported and sold.

Last Updated: May 1, 2020
Date Published: Apr. 17, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 pandemic, medical device, exceptional importation and sale of medical devices, Interim Order, regulatory requirements on imported and sold medical devices.
Federal

This interim order (IO) provides more tools for urgently addressing drug shortages related to COVID-19.

Last Updated: Apr. 30, 2021
Date Published: Oct. 16, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Interim Order, prevention and alleviation of shortages of drugs, drug shortages related to COVID-19
Federal

There is an unprecedented demand and urgent need for access to biocides during the COVID-19 pandemic. On March 1, 2021, the Minister of Health signed Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19. The interim order (IO) allows certain biocides that may not fully meet regulatory requirements to be imported and sold in Canada.

Last Updated: Apr. 30, 2021
Date Published: Mar. 1, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, Exceptional importation and sale, biocides, demand and urgent need for access, Minister of Health, Interim Order No. 2, regulatory requirements
Date modified: